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I. General methods 
(A) General. Unless otherwise noted, all chemicals and reagents were obtained from commercial 
suppliers (Sigma-Aldrich, VWR, Alfa Aesar, Combi-Blocks) and used without further purification. Di-
sulfides used to form self-assembled monolayers were purchased from ProChimia Surfaces. Silica gel 
chromatography was carried out using AMD Silica Gel 60, 230-400 mesh. 1H and 13C NMR spectra were 
recorded on a Varian Inova 300 MHz, Varian Inova 500 MHz, or Bruker Prodigy 400 MHz instrument in 
CDCl3 and are referenced to residual protio solvent signals. Data for 1H NMR are reported as follows: 
chemical shift (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sext = 
sextet, m = multiplet, dd = doublet of doublets, dt = doublet of triplets, ddd = doublet of doublet of dou-
blets), coupling constant (Hz), integration. Sonication was performed using a Qsonica Q500 sonicator. 
High-resolution mass spectra were obtained at the California Institute of Technology Mass Spectral Fa-
cility. Synthetic reactions were monitored by thin layer chromatography (TLC, Merck 60 gel plates) using 
a UV-lamp or an appropriate TLC stain for visualization. E. coli cells were grown using Luria-Bertani 
medium (LB) or Hyperbroth (AthenaES) (HB) with 0.1 mg/mL ampicillin (LBamp or HBamp). Primer 
sequences are available upon request. T5 exonuclease, Phusion polymerase, and Taq ligase were pur-
chased from New England Biolabs (NEB, Ipswich, MA). M9-N minimal medium (abbreviated as M9-N 
buffer; pH 7.4) was used as a buffering system for whole cells and lysates, unless otherwise specified. 
M9-N buffer was used without a nitrogen source; it contains 47.7 mM Na2HPO4, 22.0 mM KH2PO4, 8.6 
mM NaCl, 2.0 mM MgSO4, and 0.1 mM CaCl2. 
 
E. coli cells were grown using Luria-Bertani medium (LB) or Hyperbroth (AthenaES) (HB) with 
0.1 mg/mL ampicillin (LBamp or HBamp). Primer sequences are available upon request. T5 exonuclease, 
Phusion polymerase, and Taq ligase were purchased from New England Biolabs (NEB, Ipswich, MA). 
M9-N minimal medium (abbreviated as M9-N buffer; pH 7.4) was used as a buffering system for whole 
cells and lysates, unless otherwise specified. M9-N buffer was used without a nitrogen source; it contains 
47.7 mM Na2HPO4, 22.0 mM KH2PO4, 8.6 mM NaCl, 2.0 mM MgSO4, and 0.1 mM CaCl2 
 
(B) Chromatography. Chiral GC was conducted using an Agilent 7820A instrument (FID) and 
an Agilent CycloSil-B column (30 m × 0.32 mm, 0.25 µm film). Gas chromatography-mass spectrometry 
(GC-MS) analyses were carried out using a Shimadzu GCMS-QP2010SE system and J&W HP-5ms col-
umn (30 m × 0.25 mm, 0.25 µm film).  
 
(C) Cloning and error prone mutagenesis. pET22b(+) was used as a cloning and expression 
vector for all enzymes described in this study. Error prone mutagenesis was performed using Taq DNA 
Polymerase. The PCR products were digested with DpnI, gel purified, and ligated using Gibson MixTM.1 
The ligation mixture was used to directly transform electrocompetent E. coli strain E. cloni BL21(DE3) 
cells (Lucigen). 
 
(D) Expression of P411 variants in 96-well plates. Single colonies from LBamp agar plates were 
picked using sterile toothpicks and cultured in deep-well 96-well plates containing 3 LBamp (300 
µL/well) at 37 ºC, 220 rpm shaking, and 80% relative humidity overnight. After, HBamp (950 µL/well) 
in a deep-well 96-well plate was inoculated with an aliquot (50 µL/ well) of these overnight cultures and 
allowed to shake for 2.75 hours at 37 ºC, 220 rpm, and 80% relative humidity. The plates were cooled on 
ice for 30 minutes and the cultures were induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG) and 1.0 mM 5-aminolevulinic acid (final concentrations). Expression was conducted at 20 °C, 150 
rpm for 16–20 hours. 
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(E) Reaction screening in 96-well plate format. E. coli (E. cloni BL21(DE3)) cells in deep-well 
96-well plates were pelleted (5,000 × g, 3 min, RT) and resuspended in M9-N buffer (20 µL/well) by 
gentle vortexing. The 96-well plate was transferred into an anaerobic chamber. In the anaerobic chamber, 
reaction buffer (33 mM glucose in M9-N, 380 µL/well) was added, followed by alkane substrate (10 
µL/well, 400 mM in EtOH) and ethyl diazoacetate (10 µL/well, 400 mM in EtOH). In some cases, the 
substrates and reaction buffer were mixed together prior to addition to the plate. The plate was sealed with 
an aluminum foil and shaken at room temperature, 500 rpm in the anaerobic chamber. After 24 hours, the 
seal was removed and the reactions were worked up following the appropriate method below. 
 
Product formation screening using GC-MS.  
 
After 24 hours, a solution of 20 mM 1,3,5-trimethoxybenzene (internal standard) in a mixed sol-
vent system (cyclohexane/ ethyl acetate = 1:1, 20 µL), followed by 580 µL pure solvent, was added. The 
plate was tightly sealed with a reusable silicone mat, vortexed (15 s × 3) and centrifuged (3,000 × g, 5 
min) to completely separate the organic and aqueous layers. The organic layers (200 µL/well) were trans-
ferred to 300 µL vial inserts, which were then placed in 2 mL vials and analyzed by GC. 
 
Product formation screening by SAMDI Mass Spectrometry  
 
After 24 hours, 190 µL crude reaction mixture was aliquoted to PCR plates and frozen on dry ice. 
Plates were shipped overnight on dry ice.  
 
(1) Preparation of SAMDI Array Plate – Gold-evaporated array plates were made in-house from 
outsourced polished stainless-steel plates (Ace Metal Crafts). Specifically, purchased steel plates with 
dimensions matching standard MALDI plates (12.3cm × 8cm) were washed with hexanes, ethanol and 
water. Using an electron beam evaporator (Thermionics Laboratory Inc., Hayward, CA), the plates were 
coated at 0.02nm/s with a 5nm layer of titanium followed by a 35nm layer of gold spots (2.8 mm diameter) 
at 0.05nm/s in a 384-array fashion. Before use, plates were stored under vacuum. At least two days prior 
to screening, the plates were soaked in a 0.5 mM ethanolic solution of alkyl disulfides (Prochimea Sur-
faces) at 4℃. The solution consisted of disulfide alkanes either symmetrically terminated with tri(ethylene 
glycol) groups or asymmetrically terminated with tri(ethylene glycol) and a maleimide functional group 
in a stoichiometric ratio of 2:3 expecting to yield a self-assembled monolayer of 20% maleimide surface 
density1. The plates were removed from solution, rinsed with ethanol and dried with N2(g) immediately 
before use. 
 
(2) Deprotection of Reaction Constituents – 25 µL of each reaction was aliquoted, organizing 
four 96-well plates into one 384 plate. Liquid handling was performed by a Tecan Freedom EVO 200 
Robot. To each well, 10 µL of 100mM HCl was added using an automatic reagent dispenser (Multidrop 
Combi, Thermo Scientific). Plates were sealed with aluminum sealing tape, mixed briefly, and centrifuged 
at 5000g for 1 min. After 30 min, 3 equivalents of NaHCO3 from saturated solution was added and the 
plates were sealed, mixed and centrifuged at 5000g for 1 min. The plates were either frozen or analyzed 
using the steps below. 
 
(3) Activity Assay by SAMDI Mass Spectrometry – Using a TECAN liquid-handling robot, 3 
µL from each well were spotted to SAMDI plates. The plates were allowed to incubate for 1 hour at 37℃ 
in a humidity chamber, providing sufficient time for immobilization of the thiolated reaction constituents 
to react with the maleimide. The plates were rinsed with 1% Alconox detergent, deionized ultrafiltered 
(DIUF) water and ethanol with sufficient pressure to remove all noticeable debris, dried with a stream of 
N2(g), and coated with matrix (2’,4’,6’-trihydroxyacetophenone (THAP) in acetone (18mg/ml). Each spot 
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was analyzed in positive reflector mode by MALDI-TOF (AB Sciex 5800 series). Captured reaction con-
stituents from whole cell reactions were identified by their mass shifts relative to the unreacted maleimide. 
Analysis of more than 5100 spectra collected was performed using the analysis tools built into the 
TOF/TOF™ Series Explorer™ Software, which works to integrate the area under the curve (AUC) of the 
peak corresponding to a specified mass/charge ratio. For every spectrum in this study, the following peaks 
were integrated: 1033 Da (thiolated substrate + monolayer), 1119 Da (thiolated C-H insertion product + 
monolayer). Peaks below a signal to noise threshold set at 20 were not accepted. Each mass spectra gen-
erated for each well was used to determine the relative conversion for each variant by dividing the AUC 
of the product peak by the AUC of both the unreacted substrate and C-H insertion product peaks.  The 
conversion for the three parent enzymes on each 96-well plate were averaged and all other values normal-
ized to this value to acquire relative fold improvement for each variant. The variants with the highest fold 
improvement from each 96-well library selected for product formation screening using GC and GC-MS 
detailed above.  
(F) Expression of P411 variants. E. coli (E. cloni BL21(DE3)) cells carrying plasmid encoding 
the appropriate P411 variant were grown overnight in 5 mL LBamp. Preculture (5 mL) was used to inoc-
ulate 45 mL of HBamp in a 125 mL Erlenmeyer flask; this culture was incubated at 37 ºC, 240 rpm for 
2.25 hours. The culture was then cooled on ice (20–30 min) and induced with 0.5 mM IPTG and 1.0 mM 
5-aminolevulinic acid (final concentrations). Expression was conducted at 24 ºC, 140 rpm, for 20 hours. 
Following, E. coli cells were pelleted by centrifugation (2,600 × g, 10 min, 4 ºC or 3,000 × g, 5 min, 4 
ºC). Media was removed and the resulting cell pellet was resuspended in M9-N buffer to OD600 = 60. 
An aliquot of this cell suspension (3 mL) was taken to determine P411 concentration using the hemo-
chrome assay after lysis by sonication. When applicable, remaining cell suspension was further diluted 
with M9-N buffer to the OD600 used for the biotransformation (described in (H)) and the concentration 
of P411 protein in the biotransformation was calculated accordingly.  
 
(G) Hemochrome assay for the determination of heme protein concentration. E. coli cells 
expressing heme protein and resuspended in M9-N buffer were lysed by sonication using a Qsonica Q500 
sonicator equipped with a microtip (1 min, 1 second on, 1 second off, 35% amplitude); samples were kept 
on wet ice for this process. The resulting lysed solution was centrifuged (20,000 × g, 10 min, 4 °C) to 
remove cell debris. The supernatant (clarified lysate) was separated from the pellet and kept on ice until 
use. In a falcon tube, a solution of 0.2 M NaOH, 40% (v/v) pyridine, 0.5 mM K3Fe(CN)6 was prepared 
(pyridine-NaOH-K3Fe(CN)6 solution). Separately, a solution of 0.5 M Na2S2O4 (sodium dithionite) was 
prepared in 0.1 M NaOH. To an Eppendorf tube containing 500 µL of clarified lysate in M9-N buffer was 
added 500 µL of the pyridine-NaOH-K3Fe(CN)6 solution, mixed, and transferred to a cuvette; the UV-
Vis spectrum of the oxidized Fe(III) state was recorded immediately. To the cuvette was then added 10 
µL of the sodium dithionite solution. The cuvette was sealed with parafilm and the UV-Vis spectrum of 
the reduced Fe(II) state was recorded immediately. A cuvette containing 500 µL of M9-N, 100 µL 1 M 
NaOH, 200 µL pyridine, and 200 µL water (complete mixture without protein and K3Fe(CN)6) was used 
as a reference for all absorbance measurements. Concentrations of cytochromes P411 were determined 
using a published extinction coefficient for heme b, ε556(reduced)-540(oxidized) = 23.98 mM-1 cm-1.2 
 
(H) Biotransformations using whole E. coli cells. Suspensions of E. coli (E. cloni BL21(DE3)) 
cells expressing the appropriate heme protein variant in M9-N buffer (typically OD600 = 60) were de-
gassed by bubbling with argon in sealed vials for at least 40 minutes; the cells were kept on ice during 
this time. Separately, a solution of D-glucose (250 mM in M9-N) was degassed by sparging with argon 
for at least 30 minutes. All solutions were then transferred into an anaerobic chamber for reaction set up. 
To a 2 mL vial were added D-glucose (40 µL of 250 mM stock solution in M9-N buffer), M9-N buffer 
(typically 343.33 µL), suspension of E. coli expressing P411 (OD600 = 1, 6.67 µL), alkane substrate (5 
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µL of 400 mM stock solution in EtOH), and diazo compound (5 µL of 400 mM stock solution in EtOH) 
in the listed order. Final reaction volume was 400 µL; final concentrations were 5 mM alkane substrate, 
5 mM diazo compound, and 30 mM D-glucose. Note: reaction performed with E. coli cells resuspended 
to OD600 = 1 indicates that 6.67 µL of OD600 = 60 cells were added, and likewise for other reaction 
OD600 descriptions. The vials were sealed and shaken at room temperature and 500 rpm for 18 hours in 
the anaerobic chamber. The reactions were worked up and analyzed by GC; the reaction workup proce-
dures are outlined in detail in Section VII. The expression of heme protein was measured using the he-
mochrome assay (Section I(G)), and the concentration of heme protein in the biotransformation was cal-
culated accordingly. 
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II. Supplementary Figs. S1–S8 and Table S1 
 
 
 
 
Figure S1: Results from 3 mutational loads compared to a plate of parent enzymes. Following the proce-
dure in the experimental section, random libraries of P411-CHF(P74T) were generated using error-prone 
PCR and various concentrations of MnCl2. A mutation rate using 400µM MnCl2 was adequate to proceed 
with this enzyme. All parents are show in black.  
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Figure S2 a: Scatterplot of screening results from Figure 2 inclusive of an additional variant that was sub-
sequently identified as a false positive by GCMS (Figure S2 b). Data was collected via GCMS and SAMDI 
from a library of 70 mutants using P411-CHF(P74T) as the parent and 400 µM MnCl2 during epPCR com-
paring product to remaining substrate. Values were calculated as a fraction of product over the total of the 
remaining starting material and product formed. Correlation was determined using least squares linear re-
gression. Here a slope of 2.5 shows that the SAMDI and GC methods do not give the same uncalibrated 
measurement of yield, and is likely due to different ionization efficiencies of the reaction products. We have, 
however, verified that the SAMDI method does provide a quantitative measure of yield and allows identifica-
tion of top variants and perform evolution. 
 
Figure S2 b: Correlations of variants collected on GCMS from the random mutagenesis in Figure S2a 
library using P411-CHF(P74T) as the parent and 400 µM MnCl2 during epPCR comparing product to 
remaining substrate with product concentration corrected by an internal standard. Data showed good cor-
relation for most points; however, this direct comparison reveals a point (red) to be a false positive hit 
when only considering product and remaining substrate. Parent controls are shown in black and negative 
controls in white.  
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Figure S3: Heatmaps display the relative activity of 4,956 samples measured via SAMDI. Mutants are 
shaded and organized by relative fold improvement normalized by the average of parent controls on each 
respective 96-well plate. Visible differences in the amount of active versus inactive variants in each heat 
map can be attributed to the number of mutations in each variant. Variants identified by SAMDI as having 
a fold improvement of more than two times the relative standard deviation on the average of parent activity 
from each library were selected to be validated by GCMS. The mutant confirmed to be the most active 
was then chosen for the next round of evolution. The best confirmed variant from each round (boxed in 
blue for round 1 and in green for round 2) were used as the parent in each subsequent round of evolution. 
In the third round of experiments, none of the variants were verified either by SAMDI or via GCMS to 
have significantly improved activity over the previous parent. In the third round, we did not identify a 
variant with significantly improved activity out of the 2,496 variants screened and decided to end the 
campaign. We chose the best variant from round 2 as the final variant.   
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Figure S4: Structural visualization of amino acids mutated during evolution of P411-CHF to our final 
variant. The final variant was identified to contain 4 amino acid mutations from the initial parent with 2 
in the heme domain and 2 in the FMN domain. The following mutations were accumulated (from left to 
right): In the heme domain: P74T, I174T. In the FMN domain: Both a Q553H mutation and a stop codon 
at K639. While the P74T mutation identified in the initial parent is located in the active site, none of the 
mutated residues identified by SAMDI are more than 15 Å from the iron atom in the center of the heme 
cofactor. 
Note: The structure of the heme domain was modeled using the crystal structure of a related P411 variant 
(PDB 5UCW), which contains nine additional mutations. The structure of the FMN domain was modeled 
using the crystal structure from a related variant (PDB 1BVY). 
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Figure S5: Reproducibility in the SAMDI method. Using SAMDI, a whole-cell reaction with thioacetate-
tagged 1-methoxyhept-2-ene was deprotected and spotted 380 times on a SAMDI plate, without prior 
purification or centrifugation. 10 mL of reaction was conducted from 1 colony and 10 mM substrate at 25 
℃ for 24hours. Negative controls using P411-TrpB are located in rows D and L, columns 6 and 18. A 
standard deviation of 2.3% was found on an average yield of 27%, indicating the assay is able to discern 
active wells from non-active wells sufficiently. From these data, we subsequently calculated the resolving 
power of the technique using the m/z values for each peak and the average resolution output by the in-
strument. Here we found a value of 0.1 m/z, indicating the method’s applicability to transformations of 
minute changes in mass.  
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Figure S6: Results of screening a plate of the same clone to show the assay’s variability. Measurement 
of P411-CHF(P74T) activity with thioacetate-tagged 1-methoxyhept-2-ene in a 96-deepwell format. 1 mL 
of expressed cells was centrifuged and resuspended in 0.4 mL M9-N with 10 mM substrate at 22 ℃ for 
24 hours. Negative controls with no cells are located in rows A and H, columns 1 and 12. Each data point 
represents a separate reaction using a different clone from the same enzyme. Each reaction was depro-
tected and spotted in quadruplicates to SAMDI plates, without prior purification or centrifugation and 
averaged to give each data point. All values are then averaged. A coefficient of variation of 14% was 
found on an average yield of 48%, indicating the assay’s reproducibility in screening. An increase in 
variability outside of the SAMDI technique is expected here as a result of differences in expression and 
all experimental errors. 
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Figure S7: Using methods previously reported elsewhere,7 a diazirine-terminated monolayer was used to 
analyze the reaction products for the reaction from Figure S5, demonstrating that analysis of this reaction 
was not reliant on thiol-maleimide chemistry. Here, SAMDI-MS spectra displays the diazirine monolayer 
at m/z 1325 (after loss of nitrogen and conversion to carbene) and clear peaks corresponding to both the 
deprotected and remaining acetate-protected reaction products. Crude lysates were briefly deprotected in 
28mM HCl for 30minutes and quenched with saturated sodium bicarbonate in order to show the ability 
of this monolayer to immobilize all 4 species. No extraction or centrifugation was performed prior to 
analysis. The deprotected and acetate-protected substrate appear at m/z 1485 and m/z 1527, respectively, 
and their corresponding insertion product are seen + 86 Daltons at m/z 1571 and m/z 1613, respectively. 
Primary byproducts are seen due to reaction with water (m/z 1343) and 2,4,6-trihydroxyacetophenone 
(m/z 1493), the MALDI matrix. 
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Figure S8 (a-e): SAMDI-MS data that demonstrates the technique’s generalizability by its capacity to 
record product formation for a variety of reactions within the substrate scope of the enzyme. Because the 
expected reaction products do not contain functional groups that may be exploited for straight-forward 
immobilization, reactions were analyzed using a diazirine monolayer and conditions reported in Figure 
S7. The evolved P411 variant was used to catalyze the reaction of ethyl diazoacetate and a. (E)-1-Meth-
oxyoct-2-ene, b. Ethyl 2-(1-phenylpyrrolidin-2-yl)acetate c. Ethyl 2-(1,3-dihydroisobenzofuran-1-yl)ac-
etate d. Ethyl 2-(1-methyl-1,2,3,4-tetrahydroquinolin-2-yl)acetate and e. 1-(Methoxymethyl)-4-
methylbenzene. The peaks corresponding to the substrate and product for these reactions are as follows: 
a. m/z 1467 and 1553, b. m/z 1472 and 1558, c. m/z 1445 and 1531, d. 1472 and 1558, and e. m/z 1461 
and 1547, respectively. As expected, all product peaks are shifted +86 Da. Further knowledge of the 
differences in ionization and immobilization efficiency between the substrate and their product is required 
to quantitate yields; however, it is clear that the evolved P411 variant remains active for a number of 
substrates.  
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Table S1: Beneficial mutations discovered by SAMDI 
Gen. Percent Yield Fold Improvement Mutation TTN 
0 2.44% -- -- 637 
1 4.46% 1.83 I174T Q553H 1107 
2 6.28% 1.4 K639* 1310 
 
Note: Due to the large number of variants screened, other improved variants were identified in the course 
of this study with lower fold-improvement, however only the top variant from each round was chosen and 
characterized more rigorously.   
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III. Screening of enzymes for C–H alkylation activity 
Testing heme proteins for reaction discovery 
A composite plate of 92 heme proteins and their variants from Bacillus megaterium and 
Rhodothermus marinus were screened for formation of ethyl (E)-9-(acetylthio)-3-methoxynon-4-enoate 
from substrates (E)-S-(7-methoxyhept-5-en-1-yl) ethanethioate and ethyl diazoacetate. These proteins 
were cloned and used in other studies, including carbene Si–H insertion,3 alkene cyclopropanation,4,5 and 
alkane C-H functionalization.6 Expression of these proteins followed the procedures as described by the 
prior studies and testing for initial activity was carried out with whole E. coli cells. The general procedure 
for reaction screening in 96-well plate format (Section I (E)) was employed and the reactions were ana-
lyzed by GC-MS. Note: Since this was an initial test, proper expression of the indicated proteins was not 
verified and experimental replicates were not performed. A variant closely related to P411-CHF from 
prior alkane C-H functionalization studies,6 P411-CHF +P74T, was identified as the most promising var-
iant for evolution. 
 
IV. Directed evolution of C–H alkylation enzymes 
Error-prone libraries were generated using Taq Polymerase and differing concentrations of man-
ganese chloride, and screened in 96-well plates. Following the general screening in 96-well plate proce-
dure (Section I (E)), variants which exhibited higher formation of C–H alkylation product were identified. 
A summary of the beneficial mutation(s) is presented in Section II Supplementary Table S1. The locations 
of the selected beneficial mutations are displayed on a structural model of the P411 enzyme (Section II, 
Supplementary Fig. 4). 
Variants which were identified to show higher activity during screening were streaked out on 
LBamp agar plates. A single colony was selected, sequenced, and the TTN measured for our product using 
whole E. coli cells overexpressing the desired protein (the cell density was normalized such that each 
reaction contained the same cell density, general procedure Section I). The results are summarized in 
Supplementary Table 1. 
 
V. Nucleotide and amino acid sequences 
All heme proteins disclosed below were cloned into a pET22b(+) vector. 
DNA and amino acid sequence of P411-CHF(P74T), a previously reported cytochrome P411 variant 
which was used as the starting point for evolution: 
DNA Sequence: 
ATGACAATTAAAGAAATGCCTCAGCCAAAAACGTTTGGAGAGCTTAAAAATTTACCGTTAT
TAAACACAGATAAACCGGTTCAAGCTTTGATGAAAATTGCGGATGAATTAGGAGAAATCTT
TAAATTCGAGGCGCCTGGTCGTGTAACGCGCTACTTATCAAGTCAGCGTCTAATTAAAGAA
GCATGCGATGAATCACGCTTTGATAAAGAGTTAAGTCAAACGCTGAAATTTCTGCGTGATT
TTCTTGGAGACGGGTTAGCCACAAGCTGGACGCATGAAAAAAATTGGAAAAAAGCGCATA
ATATCTTACTTCCAAGCTTTAGTCAGCAGGCAATGAAAGGCTATCATGCGATGATGGTCGA
TATCGCCGTGCAGCTTGTTCAAAAGTGGGAGCGTCTAAATGCAGATGAGCATATTGAAGTA
TCGGAAGACATGACACGTTTAACGCTTGATACAATTGGTCTTTGCGGCTTTAACTATCGCTT
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TAACAGCTTTTACCGAGATCAGCCTCATCCATTTATTATAAGTCTGGTCCGTGCACTGGATG
AAGTAATGAACAAGCTGCAGCGAGCAAATCCAGACGACCCAGCTTATGATGAAAACAAGC
GCCAGTTTCAAGAAGATATCAAGGTGATGAACGACCTAGTAGATAAAATTATTGCAGATC
GCAAAGCAAGGGGTGAACAAAGCGATGATTTATTAACGCAGATGCTAAACGGAAAAGATC
CAGAAACGGGTGAGCCGCTTGATGACGGGAACATTCGCTATCAAATTATTACATTCTTATA
TGCGGGAGTTGAAGGTACAAGTGGTCTTTTATCATTTGCGCTGTATTTCTTAGTGAAAAATC
CACATGTATTACAAAAAGTAGCAGAAGAAGCAGCACGAGTTCTAGTAGATCCTGTTCCAA
GCTACAAACAAGTCAAACAGCTTAAATATGTCGGCATGGTCTTAAACGAAGCGCTGCGCTT
ATGGCCAACGGTTCCTTATTTTTCCCTATATGCAAAAGAAGATACGGTGCTTGGAGGAGAA
TATCCTTTAGAAAAAGGCGACGAAGTAATGGTTCTGATTCCTCAGCTTCACCGTGATAAAA
CAGTTTGGGGAGACGATGTGGAGGAGTTCCGTCCAGAGCGTTTTGAAAATCCAAGTGCGAT
TCCGCAGCATGCGTTTAAACCGTTTGGAAACGGTCAGCGTGCGTCTATCGGTCAGCAGTTC
GCTCTTCATGAAGCAACGCTGGTACTTGGTATGATGCTAAAACACTTTGACTTTGAAGATC
ATACAAACTACGAGCTCGATATTAAAGAACTGCTTACGTTAAAACCTAAAGGCTTTGTGGT
AAAAGCAAAATCGAAAAAAATTCCGCTTGGCGGTATTCCTTCACCTAGCACTGAACAGTCT
GCTAAAAAAGTACGCAAAAAGGCAGAAAACGCTCATAATACGCCGCTGCTTGTGCTATAC
GGTTCAAATATGGGTACCGCTGAAGGAACGGCGCGTGATTTAGCAGATATTGCAATGAGC
AAAGGATTTGCACCGCAGGTCGCAACGCTTGATTCACACGCCGGAAATCTTCCGCGCGAAG
GAGCTGTATTAATTGTAACGGCGTCTTATAACGGTCATCCGCCTGATAACGCAAAGCAATT
TGTCGACTGGTTAGACCAAGCGTCTGCTGATGAAGTAAAAGGCGTTCGCTACTCCGTATTT
GGATGCGGCGATAAAAACTGGGCTACTACGTATCAAAAAGTGCCTGCTTTTATCGATGAAA
CGCTTGCCGCTAAAGGGGCAGAAAACATCGCTGACCGCGGTGAAGCAGATGCAAGCGACG
ACTTTGAAGGCACATATGAAGAATGGCGTGAACATATGTGGAGTGACGTAGCAGCCTACTT
TAACCTCGACATTGAAAACAGTGAAGATAATAAATCTACTCTTTCACTTCAATTTGTCGAC
AGCGCCGCGGATATGCCGCTTGCGAAAATGCACGGTGCGTTTTCAACGCTCGAGCACCACC
ACCACCACCACTGA 
 
Amino Acid Sequence: 
MTIKEMPQPKTFGELKNLPLLNTDKPVQALMKIADELGEIFKFEAPGRVTRYLSSQRLIKEACD
ESRFDKELSQTLKFLRDFLGDGLATSWTHEKNWKKAHNILLPSFSQQAMKGYHAMMVDIAVQ
LVQKWERLNADEHIEVSEDMTRLTLDTIGLCGFNYRFNSFYRDQPHPFIISLVRALDEVMNKLQ
RANPDDPAYDENKRQFQEDIKVMNDLVDKIIADRKARGEQSDDLLTQMLNGKDPETGEPLDD
GNIRYQIITFLYAGVEGTSGLLSFALYFLVKNPHVLQKVAEEAARVLVDPVPSYKQVKQLKYV
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GMVLNEALRLWPTVPYFSLYAKEDTVLGGEYPLEKGDEVMVLIPQLHRDKTVWGDDVEEFRP
ERFENPSAIPQHAFKPFGNGQRASIGQQFALHEATLVLGMMLKHFDFEDHTNYELDIKELLTLK
PKGFVVKAKSKKIPLGGIPSPSTEQSAKKVRKKAENAHNTPLLVLYGSNMGTAEGTARDLADI
AMSKGFAPQVATLDSHAGNLPREGAVLIVTASYNGHPPDNAKQFVDWLDQASADEVKGVRY
SVFGCGDKNWATTYQKVPAFIDETLAAKGAENIADRGEADASDDFEGTYEEWREHMWSDVA
AYFNLDIENSEDNKSTLSLQFVDSAADMPLAKMHGAFSTLEHHHHHH* 
 
DNA and amino acid sequence of our final variant, an evolved C–H alkylation enzyme: 
DNA Sequence: 
ATGACAATTAAAGAAATGCCTCAGCCAAAAACGTTTGGAGAGCTTAAAAATTTACCGTTAT
TAAACACAGATAAACCGGTTCAAGCTTTGATGAAAATTGCGGATGAATTAGGAGAAATCTT
TAAATTCGAGGCGCCTGGTCGTGTAACGCGCTACTTATCAAGTCAGCGTCTAATTAAAGAA
GCATGCGATGAATCACGCTTTGATAAAGAGTTAAGTCAAACGCTGAAATTTCTGCGTGATT
TTCTTGGAGACGGGTTAGCCACAAGCTGGACGCATGAAAAAAATTGGAAAAAAGCGCATA
ATATCTTACTTCCAAGCTTTAGTCAGCAGGCAATGAAAGGCTATCATGCGATGATGGTCGA
TATCGCCGTGCAGCTTGTTCAAAAGTGGGAGCGTCTAAATGCAGATGAGCACATTGAAGTA
TCGGAAGACATGACACGCTTAACGCTTGATACAATTGGTCTTTGCGGCTTTAACTATCGCTT
TAACAGCTTTTACCGAGATCAGCCTCATCCATTTACTATAAGTCTGGTCCGTGCACTGGATG
AAGTAATGAACAAGCTGCAGCGAGCAAATCCAGACGACCCAGCTTATGATGAAAACAAGC
GCCAGTTTCAAGAAGATATCAAGGTGATGAACGACCTAGTAGATAAAATTATTGCAGATC
GCAAAGCAAGGGGTGAACAAAGCGATGATTTATTAACGCAGATGCTAAACGGAAAAGATC
CAGAAACGGGTGAGCCGCTTGATGACGGGAACATTCGCTATCAAATTATTACATTCTTATA
TGCGGGAGTTGAAGGTACAAGTGGTCTTTTATCATTTGCGCTGTATTTCTTAGTGAAAAATC
CACATGTATTACAAAAAGTAGCAGAAGAAGCAGCACGAGTTCTAGTAGATCCTGTTCCAA
GCTACAAACAAGTCAAACAGCTTAAATATGTCGGCATGGTCTTAAACGAAGCGCTGCGCTT
ATGGCCAACGGTTCCTTATTTTTCCCTATATGCGAAAGAAGATACGGTGCTTGGAGGAGAA
TATCCTTTAGAAAAAGGCGACGAAGTAATGGTTCTGATTCCTCAGCTTCACCGTGATAAAA
CAGTTTGGGGAGACGATGTGGAGGAGTTCCGTCCAGAGCGTTTTGAAAATCCAAGTGCGAT
TCCGCAGCATGCGTTTAAACCGTTTGGAAACGGTCAGCGTGCGTCTATCGGTCAGCAGTTC
GCTCTTCATGAAGCAACGCTGGTACTTGGTATGATGCTAAAACACTTTGACTTTGAAGATC
ATACAAACTACGAGCTCGATATTAAAGAACTGCTTACGTTAAAACCTAAAGGCTTTGTGGT
AAAAGCAAAATCGAAAAAAATTCCGCTTGGCGGTATTCCTTCACCTAGCACTGAACAGTCT
GCTAAAAAAGTACGCAAAAAGGCAGAAAACGCTCATAATACGCCGCTGCTTGTGCTATAC
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GGTTCAAATATGGGTACCGCTGAAGGAACGGCGCGTGATTTAGCAGATATTGCAATGAGC
AAAGGATTTGCACCGCAGGTCGCAACGCTTGATTCACACGCCGGAAATCTTCCGCGCGAAG
GAGCTGTATTAATTGTAACGGCGTCTTATAACGGTCATCCGCCTGATAACGCAAAGCAATT
TGTCGACTGGTTAGACCATGCGTCTGCTGATGAAGTAAAAGGCGTTCGCTACTCCGTATTT
GGATGCGGCGATAAAAACTGGGCTACTACGTATCAAAAAGTGCCTGCTTTTATCGATGAAA
CGCTTGCCGCTAAAGGGGCAGAAAACATCGCTGACCGCGGTGAAGCAGATGCAAGCGACG
ACTTTGAAGGCACATATGAAGAATGGCGTGAACATATGTGGAGTGACGTAGCAGCCTACTT
TAACCTCGACATTGAAAACAGTGAAGATAATTAA 
 
Amino Acid Sequence: 
MTIKEMPQPKTFGELKNLPLLNTDKPVQALMKIADELGEIFKFEAPGRVTRYLSSQRLIKEACD
ESRFDKELSQTLKFLRDFLGDGLATSWTHEKNWKKAHNILLPSFSQQAMKGYHAMMVDIAVQ
LVQKWERLNADEHIEVSEDMTRLTLDTIGLCGFNYRFNSFYRDQPHPFTISLVRALDEVMNKL
QRANPDDPAYDENKRQFQEDIKVMNDLVDKIIADRKARGEQSDDLLTQMLNGKDPETGEPLD
DGNIRYQIITFLYAGVEGTSGLLSFALYFLVKNPHVLQKVAEEAARVLVDPVPSYKQVKQLKY
VGMVLNEALRLWPTVPYFSLYAKEDTVLGGEYPLEKGDEVMVLIPQLHRDKTVWGDDVEEFR
PERFENPSAIPQHAFKPFGNGQRASIGQQFALHEATLVLGMMLKHFDFEDHTNYELDIKELLTL
KPKGFVVKAKSKKIPLGGIPSPSTEQSAKKVRKKAENAHNTPLLVLYGSNMGTAEGTARDLAD
IAMSKGFAPQVATLDSHAGNLPREGAVLIVTASYNGHPPDNAKQFVDWLDHASADEVKGVRY
SVFGCGDKNWATTYQKVPAFIDETLAAKGAENIADRGEADASDDFEGTYEEWREHMWSDVA
AYFNLDIENSEDN* 
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VI. Chemical synthesis and characterization 
General Procedure A: Methylation of alcohols  
To a 250 mL round bottom flask was added NaH (60% dispersion in mineral oil, 15–30 mmol, 1.2–1.5 
equiv.). The flask was evacuated and filled with argon (3 times). Anhydrous THF (45–80 mL) was added 
by syringe and the reaction mixture was cooled to 0 °C in an ice bath. Alcohol (10–20 mmol, 1.0 equiv.) 
in THF (5–10 mL) was added dropwise and the reaction mixture was allowed to warm to room tempera-
ture and stirred for 30 minutes. Following, iodomethane (20–40 mmol, 2.0 equiv.) in THF (10 mL) was 
added and the reaction was stirred at room temperature (8–15 hours). The reaction was quenched by the 
addition of brine (60 mL) or NH4Cl (sat. aq., 60 mL) and the phases were separated. The aqueous layer 
was extracted with diethyl ether (3 × 60 mL); the combined organics were washed with aq. sodium thio-
sulfate (10% w/v, 50 mL, when necessary), dried over Na2SO4 and concentrated under reduced pressure. 
Purification by silica column chromatography with hexanes / ethyl acetate or pentane / diethyl ether af-
forded compounds the desired products in 45–60% yield. 
 
General Procedure B: Thioacetate Tagging of alkyl bromines  
To a 100 mL round bottom flask was added alkyl bromide (1-10 mmol, 1 equiv.) in acetone (10-50 mL). 
Potassium thioacetate (6-60 mmol, 6.0 equiv.) in acetone was added and the reaction mixture was stirred 
for up two days until the bromide was fully consumed as indicated by TLC. Solvent was removed under 
reduced pressure and crude product was purified by silica column chromatography (hexanes / ethyl ace-
tate) afforded the desired products in 95–99% yield. 
 
(E)-S-(7-methoxyhept-5-en-1-yl) ethanethioate 
To a 100 mL flamed dried flask was added Grubbs’ catalyst 2nd generation (85 mg, 1 mol%). The flask 
was then evacuated and backfilled with argon three times. Under argon, a dry CH2Cl2 solution containing 
6-bromo-1-hexene (1.63 g, 10 mmol, 1.0 equiv.) and crotonaldehyde (3.50 g, 50 mmol, 5.0 equiv.) was 
added to the flask. The mixture was stirred under reflux for 20 hours and then cooled to room temperature 
and filtered through a silica plug. The solvent was removed under reduced pressure and the crude product 
was purified by flash chromatography (hexanes / ethyl acetate) to give (E)-7-bromohept-2-enal (1.6 g, 
84% yield). This product was then dissolved in 10 mL dry THF and then added slowly to a suspension of 
NaBH4 (375 mg, 10 mmol, 1.0 equiv.) in dry THF (10 mL) at 0 °C. To this reaction mixture, iodine (1.27 
g, 5 mmol, 0.5 equiv.) in 10 mL of THF was slowly added at 0 °C. Reaction was stirred until the aldehyde 
was fully reduced as indicated by TLC. The reaction was quenched with NH4Cl (sat. aq.), the phases were 
separated, and the aqueous phase was extracted with ethyl acetate (3 × 20 mL). The combined organic 
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layers were washed with brine and dried over Na2SO4. The solvent was removed under reduced pressure 
and the crude alcohol product was used directly without purification. General Procedure A was used for 
the methylation step and General Procedure B was used for the thioacetate tagging. The final product 
was obtained with 50% overall yield (1.01g, 5 mmol).  
 1H NMR (400 MHz, Chloroform-d) δ 5.67 (dtt, J = 15.4, 6.5, 1.1 Hz, 1H), 5.54 (dtt, J 
= 15.4, 6.1, 1.3 Hz, 1H), 3.85 (dq, J = 6.0, 1.0 Hz, 2H), 3.31 (s, 3H), 2.86 (t, J = 7.2 Hz, 
2H), 2.32 (s, 3H), 2.06 (tdq, J = 7.5, 6.6, 1.1 Hz, 2H), 1.64 – 1.53 (m, 2H), 1.53 – 1.39 
(m, 2H). 13C NMR (101 MHz, CDCl3) δ 195.98, 134.03, 126.66, 77.36, 77.04, 76.72, 73.18, 57.75, 31.75, 
30.65, 29.02, 28.95, 28.17. HRMS (EI) m/z: 202.1031 (M+ ˙); calc. for C10H18SO2: 202.1028. 
 
(E)-1-Methoxyoct-2-ene 
Prepared from (E)-oct-2-en-1-ol using General Procedure A. This compound is known in the literature6. 
1H NMR (400 MHz, CDCl3) δ 5.70 (dtt, J = 15.6, 6.6, 1.2 Hz, 1H), 5.54 (dtt, J = 15.3, 
6.2, 1.4 Hz, 1H), 3.86 (dq, J = 6.2, 1.0 Hz, 2H), 3.31 (s, 3H), 2.08 – 1.99 (m, 2H), 1.43 
– 1.34 (m, 2H), 1.34 – 1.21 (m, 4H), 0.88 (t, J = 7.0 Hz, 3H). 13C NMR (101 MHz, 
CDCl3) δ 135.2, 126.1, 73.5, 57.8, 32.4, 31.5, 28.9, 22.7, 14.2. 
 
1-(Methoxymethyl)-4-methylbenzene  
Prepared from p-tolylmethanol using General Procedure A. This compound is known in the literature6. 
1H NMR (400 MHz, CDCl3) δ 7.23 (d, J = 8.0 Hz, 2H), 7.17 (d, J = 7.9 Hz, 2H), 
4.43 (s, 2H), 3.37 (s, 3H), 2.35 (s, 3H). 
 
Ethyl (E)-9-(acetylthio)-3-methoxynon-4-enoate 
To a 100 mL flamed dried flask was added Grubbs’ catalyst 2nd generation (85 mg, 1 mol%). The flask 
was then evacuated and backfilled with argon three times. Under argon, a dry CH2Cl2 solution containing 
6-bromo-1-hexene (1.63 g, 10 mmol, 1.0 equiv.) and crotonaldehyde (3.50 g, 50 mmol, 5.0 equiv.) was 
added to the flask. The mixture was stirred under reflux for 20 hours and then cooled to room temperature 
and filtered through a silica plug. The solvent was removed under reduced pressure and the crude product 
was purified by flash chromatography (hexanes / ethyl acetate) to give (E)-7-bromohept-2-enal (1.6 g, 
84% yield).  
In a dry 100 mL round bottom flask, under argon, a solution of diisopropylamine (3.3 mmol, 1.1 equiv.) 
in THF (15 mL) was cooled to -78 °C and kept at this temperature for the remainder of the reaction. n-
Butyllithium (3.3 mmol, 1.1 equiv., 1.6 or 2.5 M in hexanes) was added dropwise and the resulting mixture 
SAc
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was stirred for 15-30 min. Ethyl acetate (3 mmol, 1.0 equiv.) was added dropwise and the mixture was 
stirred for an additional 30-45 min. Then, neat aldehyde (3.3 mmol, 1.1 equiv.) was added slowly and the 
solution was stirred for a further 3 hours. The reaction mixture was quenched at -78 °C by the addition of 
NH4Cl (sat. aq., 30 mL) and allowed to thaw to room temperature. Phases were separated and the aqueous 
phase was extracted with ethyl acetate or diethyl ether (3 × 20–30 mL). The combined organics were 
washed with NH4Cl (sat. aq., 2 × 10–15 mL), brine (10 mL), dried over Na2SO4 and concentrated under 
reduced pressure. Purification by silica column chromatography with hexanes / ethyl acetate afforded the 
desired aldol adducts in 75% yield. General Procedure A was used for the methylation step and General 
Procedure B was used for the thioacetate tagging. The final product was obtained with 40% overall yield 
(1.15g, 4 mmol). 
1H NMR (400 MHz, Chloroform-d) δ 5.68 (dtd, J = 15.4, 6.8, 0.8 Hz, 1H), 5.31 (ddt, J 
= 15.4, 8.1, 1.4 Hz, 1H), 4.14 (qd, J = 7.1, 0.7 Hz, 2H), 3.97 (tdd, J = 8.1, 5.5, 0.8 Hz, 
1H), 3.25 (s, 3H), 2.86 (t, J = 7.2 Hz, 2H), 2.59 (dd, J = 14.9, 8.1 Hz, 1H), 2.42 (dd, J = 
15.0, 5.5 Hz, 1H), 2.32 (s, 3H), 2.16 – 2.00 (m, 2H), 1.64 – 1.53 (m, 3H), 1.53 – 1.39 
(m, 2H), 1.25 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 195.93, 171.04, 134.44, 
129.21, 78.73, 77.34, 77.03, 76.71, 60.46, 56.16, 41.34, 31.61, 30.66, 28.99, 28.90, 28.16, 14.25. HRMS 
(EI) m/z: 288.1388 (M+ ˙); calc. for C14H24SO4: 288.1395. 
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VII. Small scale enzymatic reactions and product calibration curve 
Enzymatic reactions performed on analytical scale were conducted following the general procedure de-
scribed below, also described in Section I (H). Product formation was quantified by GC based on the 
calibration curve of the chemically synthesized compound. TTN is defined as the amount of product di-
vided by total heme protein as measured by the hemochrome assay (Section I (G)). Analysis data pre-
sented in this section are for results shown in Fig. 3 of the main text.  
General procedure for biotransformations using whole E. coli cells  
Suspensions of E. coli expressing the appropriate heme protein variant in M9-N buffer (OD600 = 
30) were degassed by bubbling with argon in sealed vials for at least 40 minutes; the cells were kept on 
ice during this time. Separately, a solution of D-glucose (250 mM in M9-N) was degassed by sparging 
with argon for at least 30 minutes. To a 2 mL vial was added a suspension of E. coli expressing heme 
protein (OD600 = 1, 390 µL) in M9-N with glucose. In the anaerobic chamber, alkane substrate (5 µL of 
400 mM stock solution in EtOH), and ethyl diazoacetate (5 µL of 400 mM stock solution in EtOH) were 
added in the listed order. Final reaction volume was 400 µL; final concentrations were 5 mM alkane 
substrate, 5 mM ethyl diazoacetate, and 30 mM D-glucose. The vials were sealed and shaken at room 
temperature and 500 rpm for 18 hours in the anaerobic chamber. The expression of heme protein was 
measured using the hemochrome assay (Section I (G)), and the concentration of heme protein in the bio-
transformation was calculated accordingly.  Reactions in figure S7 were run at OD30 with 10 mM of each 
reactant, and the volumes of each part were adjusted to maintain the concentrations of each other reaction 
constituent. 
Reaction workup for quantitative GC analysis. Internal standard 1,3,5-trimethoxybenzene (20 µL 
of 20 mM stock solution in cyclohexane) was added to the reaction vial followed by mixed solvent (cy-
clohexane / ethyl acetate = 1 : 1, 600 µL). The mixture was transferred to a 1.5 mL microcentrifuge tube, 
vortexed (10 seconds, 3 times), and centrifuged (20,000 × g, 5 minutes) to completely separate the organic 
and aqueous layers. The organic layer was taken for GC analysis.  
GC calibration curve preparation  
Stock solutions of chemically synthesized products at various concentrations (0.2 to 200 mM in 
EtOH) were prepared. To a microcentrifuge tube were added 360 µL M9-N buffer, 20 µL product stock 
solution, 20 µL internal standard (20 mM 1,3,5-trimethoxybenzene in cyclohexane), and 600 µL mixed 
solvent system (cyclohexane : ethyl acetate = 1:1). The mixture was vortexed (10 seconds, 3 times) then 
centrifuged (20,000 × g, 5 min) to completely separate the organic and aqueous layers. The organic layer 
was removed for GC analysis. The standard curves plot product concentration in mM (y-axis) against the 
ratio of product area to internal standard area on the GC (x-axis). 
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Ethyl (E)-9-(acetylthio)-3-methoxynon-4-enoate 
GC calibration curve with 1,3,5-trimethoxybenzene as internal standard (IS) 
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VIII. Determination of enantioselectivity 
Enantioselectivity of the enzymatic C–H alkylation product was determined by chiral GC analysis. A 
representative trace, and conditions, are shown below. The absolute configuration of the synthesized prod-
uct was assigned to be (S) by analogy to the chiral GC separation of Ethyl (E)-3-methoxydec-4-enoate 
reported in the literature.4 
 
Ethyl (E)-9-(acetylthio)-3-methoxynon-4-enoate 
Cyclosil-B column: 140 °C  
 
 
 
 
 
Retention Time (min) Area (mAu*s) Area % Retention Time (min) Area (mAu*s) Area %
245.014 3718.4 50.505 244.894 83.8 9.253
245.254 3644.2 49.495 245.168 821.4 90.747
Total 7362.6 100 Total 905.2 100
Retention Time (min) Area (mAu*s) Area % Retention Time (min) Area (mAu*s) Area %
244.886 106.1 8.676 244.889 152.4 8.739
245.17 1116.6 91.324 245.171 1591.1 91.261
Total 1222.7 100 Total 1743.5 100
rac P411-CHF +P74T
P411-CHF +P74T + I174T +Q553H P411-CHF +P74T + I174T +Q553H +K639*
Enz Produced 
Pdt Std 
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IX. NMR Spectra 
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